Ironwood Pharmaceuticals | 贸易债权人



金融业
股票价格
USD
资产
USD 396.06M
现金及等价物
USD 140.41M
销售成本
USD 29.83M
流动资产
USD 273.84M
流动负债
USD 242.5M
债务
USD 583.99M
EBIT
USD 33.22M
EBITDA
USD 81.81M
员工
267
EPS每股收益
USD -0.01
股本和储备
USD -264.16M
销售毛利
USD 85.24M
债务利息支出
USD 8.74M
利息收入
USD 778K
贷款资金
USD 583.99M
市值
USD 525.9M
净收入
USD 3.19M
营业费用
USD 57.33M
营业利润
USD 33.22M
普通股股本
USD 160K
PE价格收益
USD 204.24
税前利润
USD 68.02M
销售收入
USD 47.71M
销售和管理费用
USD 33.33M
贸易债权人
USD 1.61M
应收帐款人
USD 81.89M


贸易债权人 更改 日
Acadia Pharmaceuticals USD 10.9M 10.84M 2025-12
Agios Pharmaceuticals USD 18.36M 1.2M 2025-12
Akebia Therapeutics USD 21.18M 11.1M 2025-12
Almirall EUR 258.05M 58.66M 2025-12
Alnylam Pharmaceuticals USD 115.72M 1.87M 2025-12
Amarin USD 36.71M 8M 2025-09
Ardelyx USD 18.39M 3.29M 2025-09
Astellas Pharma JPY 181.95B 13.3B 2025-12
AstraZeneca USD 25.28B 252M 2025-12
Charles River Laboratories USD 148.8M 20.82M 2025-12
Coherus Biosciences USD 24.89M 12.73M 2025-09
Emergent BioSolutions USD 112.2M 500K 2023-12
Esperion Therapeutics USD 77.51M 2.81M 2025-09
Exact Sciences USD 175.87M 46.51M 2025-12
Halozyme Therapeutics USD 20.9M 5.54M 2025-12
Incyte USD 1.63B 1.46B 2025-12
Ironwood Pharmaceuticals USD 1.61M 224K 2025-09
Karyopharm Therapeutics USD 5.39M 2.8M 2025-09
Lexicon Pharmaceuticals USD 5.9M 4.79M 2025-06
MacroGenics USD 5.94M 1.28M 2025-09
Moderna USD 317M 50M 2025-12
Myriad Genetics USD 31.8M 900K 2025-09
Pacira USD 17.69M 12.44M 2025-09
PTC Therapeutics USD 45.49M 8.87M 2025-12
Puma Biotechnology USD 6.39M 962K 2025-09
Sarepta Therapeutics USD 280.84M 186.83M 2025-12
Takeda JPY 467.59B 28.61B 2025-12
Ultragenyx Pharmaceutical USD 40.57M 6.33M 2025-09
Vanda Pharmaceuticals USD 39.09M 33.28M 2024-12


Ironwood Pharmaceuticals 贸易债权人 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.